Page 2 - Phase Labs News Today

Stock Analysts’ downgrades for Tuesday, October 3rd: American Electric Power (NASDAQ:AEP) was downgraded by analysts at StockNews.com from a hold rating to a sell rating. Affiliated Managers Group (NYSE:AMG) was downgraded by analysts at StockNews.com from a buy rating to a hold rating. AutoNation (NYSE:AN) was downgraded by analysts at StockNews.com from a buy rating […]

ProPhase Labs, Inc. (NASDAQ:PRPH – Get Free Report) was the recipient of a significant decrease in short interest during the month of September. As of September 15th, there was short interest totalling 310,300 shares, a decrease of 13.8% from the August 31st total of 360,100 shares. Based on an average daily volume of 43,600 shares, […]

ProPhase Labs, Inc. (NASDAQ:PRPH – Get Free Report)’s stock price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $7.25 and traded as low as $4.35. ProPhase Labs shares last traded at $4.54, with a volume of 70,859 shares trading hands. Wall Street Analysts Forecast […]

ProPhase Labs (NASDAQ:PRPH – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Monday. Several other equities research analysts have also commented on the stock. TheStreet lowered shares of ProPhase Labs from a “b-” rating to a “c” rating in a research […]

Analysts’ upgrades for Monday, September 11th: Accenture (NYSE:ACN) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. Antero Midstream (NYSE:AM) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. Ascendis Pharma A/S (NASDAQ:ASND) was upgraded by analysts at StockNews.com from a sell rating to a […]

ProPhase Labs, Inc. (NASDAQ:PRPH – Free Report) – HC Wainwright dropped their Q3 2023 EPS estimates for ProPhase Labs in a report released on Monday, August 14th. HC Wainwright analyst Y. Chen now anticipates that the company will post earnings per share of ($0.19) for the quarter, down from their prior forecast of ($0.17). HC […]

Garden City, NY, Aug. 10, 2023 -- ProPhase Labs, Inc. Conference Call and Webcast Details Management will host a conference call at 11:00 AM ET, Thursday, August 10, 2023, to provide an update... -Today at 10:40 am- MarketScreener

ProPhase Labs (NASDAQ:PRPH – Free Report) and RAPT Therapeutics (NASDAQ:RAPT – Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership. Profitability This table compares ProPhase Labs and RAPT Therapeutics’ […]

RAPT Therapeutics (NASDAQ:RAPT – Free Report) and ProPhase Labs (NASDAQ:PRPH – Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, valuation and risk. Analyst Ratings This is a breakdown of recent ratings […]

PRPH | Complete ProPhase Labs Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.